2020 Q1 Form 10-Q Financial Statement

#000149315220008749 Filed on May 14, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $8.429M $8.471M
YoY Change -0.5% 101.65%
Cost Of Revenue $5.480M $5.696M
YoY Change -3.79% 154.97%
Gross Profit $2.950M $2.776M
YoY Change 6.27% 41.09%
Gross Profit Margin 34.99% 32.76%
Selling, General & Admin $1.311M $1.488M
YoY Change -11.92% 48.78%
% of Gross Profit 44.43% 53.6%
Research & Development $28.58K $20.09K
YoY Change 42.28% -46.01%
% of Gross Profit 0.97% 0.72%
Depreciation & Amortization $99.95K $100.2K
YoY Change -0.22% 80.19%
% of Gross Profit 3.39% 3.61%
Operating Expenses $1.383M $1.729M
YoY Change -20.02% 80.92%
Operating Profit $1.567M $1.047M
YoY Change 49.7% 3.46%
Interest Expense $101.4K $129.0K
YoY Change -21.38% 1643.34%
% of Operating Profit 6.47% 12.33%
Other Income/Expense, Net
YoY Change
Pretax Income $1.767M $1.293M
YoY Change 36.58% 28.63%
Income Tax $435.0K $379.1K
% Of Pretax Income 24.62% 29.31%
Net Earnings $1.265M $1.011M
YoY Change 25.07% 43.7%
Net Earnings / Revenue 15.0% 11.94%
Basic Earnings Per Share
Diluted Earnings Per Share $102.8K $85.57K
COMMON SHARES
Basic Shares Outstanding 12.24M shares 11.71M shares
Diluted Shares Outstanding 12.30M shares 11.82M shares

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.412M $3.696M
YoY Change -7.67% -44.09%
Cash & Equivalents $3.412M $3.696M
Short-Term Investments
Other Short-Term Assets $302.2K $292.8K
YoY Change 3.24% 72.21%
Inventory $8.903M $8.737M
Prepaid Expenses $302.2K $292.8K
Receivables $7.672M $7.592M
Other Receivables $0.00 $0.00
Total Short-Term Assets $20.29M $20.32M
YoY Change -0.14% 43.73%
LONG-TERM ASSETS
Property, Plant & Equipment $3.986M $3.745M
YoY Change 6.46% 99.49%
Goodwill $2.534M $2.534M
YoY Change 0.0%
Intangibles $2.908M $3.084M
YoY Change -5.71%
Long-Term Investments $2.799M $2.002M
YoY Change 39.84% 27841.92%
Other Assets $1.545M $1.901M
YoY Change -18.71% 8.01%
Total Long-Term Assets $14.53M $14.09M
YoY Change 3.09% 276.66%
TOTAL ASSETS
Total Short-Term Assets $20.29M $20.32M
Total Long-Term Assets $14.53M $14.09M
Total Assets $34.82M $34.41M
YoY Change 1.18% 92.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $966.0K $1.461M
YoY Change -33.88% 317.42%
Accrued Expenses $388.1K $343.4K
YoY Change 13.0%
Deferred Revenue
YoY Change
Short-Term Debt $3.556M $4.182M
YoY Change -14.97% 1572.82%
Long-Term Debt Due $1.197M $721.4K
YoY Change 65.96% 258.55%
Total Short-Term Liabilities $8.362M $8.557M
YoY Change -2.28% 287.46%
LONG-TERM LIABILITIES
Long-Term Debt $2.982M $3.425M
YoY Change -12.93% 3304.75%
Other Long-Term Liabilities $311.7K $396.1K
YoY Change -21.31%
Total Long-Term Liabilities $2.982M $3.425M
YoY Change -12.93% 3304.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.362M $8.557M
Total Long-Term Liabilities $2.982M $3.425M
Total Liabilities $13.21M $14.24M
YoY Change -7.21% 516.78%
SHAREHOLDERS EQUITY
Retained Earnings $3.721M $3.363M
YoY Change 10.65% 191.06%
Common Stock $12.24K $11.71K
YoY Change 4.52% -99.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.13M $17.68M
YoY Change
Total Liabilities & Shareholders Equity $34.82M $34.41M
YoY Change 1.18% 92.49%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $1.265M $1.011M
YoY Change 25.07% 43.7%
Depreciation, Depletion And Amortization $99.95K $100.2K
YoY Change -0.22% 80.19%
Cash From Operating Activities -$1.154M -$1.694M
YoY Change -31.89% 832.01%
INVESTING ACTIVITIES
Capital Expenditures $96.28K $1.276M
YoY Change -92.45% 16917.94%
Acquisitions
YoY Change
Other Investing Activities -$721.4K -$996.0K
YoY Change -27.58% -10060.0%
Cash From Investing Activities -$817.6K -$2.272M
YoY Change -64.01% 182084.12%
FINANCING ACTIVITIES
Cash Dividend Paid $590.5K
YoY Change
Common Stock Issuance & Retirement, Net $24.75K $10.85K
YoY Change 128.11% -70.16%
Debt Paid & Issued, Net $201.0K
YoY Change
Cash From Financing Activities $745.5K $599.0K
YoY Change 24.45% -4397.85%
NET CHANGE
Cash From Operating Activities -$1.154M -$1.694M
Cash From Investing Activities -$817.6K -$2.272M
Cash From Financing Activities $745.5K $599.0K
Net Change In Cash -$1.222M -$3.162M
YoY Change -61.34% 1505.39%
FREE CASH FLOW
Cash From Operating Activities -$1.154M -$1.694M
Capital Expenditures $96.28K $1.276M
Free Cash Flow -$1.250M -$2.970M
YoY Change -57.91% 1469.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3634670 usd
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3695933 usd
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3412265 usd
CY2019Q4 us-gaap Inventory Net
InventoryNet
9182786 usd
CY2020Q1 us-gaap Inventory Net
InventoryNet
8902873 usd
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
218638 usd
CY2020Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
302242 usd
CY2019Q4 us-gaap Assets Current
AssetsCurrent
17506309 usd
CY2020Q1 us-gaap Assets Current
AssetsCurrent
20289851 usd
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4005676 usd
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3986428 usd
CY2019Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
30630 usd
CY2020Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8540 usd
CY2019Q4 us-gaap Assets
Assets
32380417 usd
CY2020Q1 us-gaap Assets
Assets
34819594 usd
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
213221 usd
CY2020Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
119511 usd
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1770105 usd
CY2020Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
1741067 usd
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1196722 usd
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1197186 usd
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6793194 usd
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
8361606 usd
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3183671 usd
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2982180 usd
CY2019Q4 us-gaap Liabilities
Liabilities
11919041 usd
CY2020Q1 us-gaap Liabilities
Liabilities
13214126 usd
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
12216 usd
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
12241 usd
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
17911227 usd
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
17059301 usd
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
17678858 usd
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
19130306 usd
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12215545 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12240545 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12215545 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12240545 shares
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5479947 usd
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5695889 usd
CY2020Q1 us-gaap Gross Profit
GrossProfit
2949539 usd
CY2019Q1 us-gaap Gross Profit
GrossProfit
2775587 usd
CY2020Q1 us-gaap Salaries And Wages
SalariesAndWages
535433 usd
CY2019Q1 us-gaap Salaries And Wages
SalariesAndWages
530677 usd
CY2020Q1 us-gaap Officers Compensation
OfficersCompensation
204543 usd
CY2019Q1 us-gaap Officers Compensation
OfficersCompensation
265092 usd
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
65621 usd
CY2019Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
52706 usd
CY2020Q1 FSI Investor Relations And Transfer Agent Fee
InvestorRelationsAndTransferAgentFee
18624 usd
CY2019Q1 FSI Investor Relations And Transfer Agent Fee
InvestorRelationsAndTransferAgentFee
16450 usd
CY2020Q1 us-gaap Other General Expense
OtherGeneralExpense
39392 usd
CY2019Q1 us-gaap Other General Expense
OtherGeneralExpense
46882 usd
CY2020Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
131569 usd
CY2019Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
102735 usd
CY2020Q1 us-gaap Interest Expense
InterestExpense
101425 usd
CY2019Q1 us-gaap Interest Expense
InterestExpense
129007 usd
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
51053 usd
CY2019Q1 us-gaap Professional Fees
ProfessionalFees
158770 usd
CY2020Q1 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
55362 usd
CY2019Q1 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
96284 usd
CY2020Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
11876 usd
CY2019Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
11028 usd
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28578 usd
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20086 usd
CY2020Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
2358 usd
CY2019Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
19757 usd
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
57727 usd
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-92064 usd
CY2020Q1 us-gaap Utilities Operating Expense
UtilitiesOperatingExpense
4305 usd
CY2019Q1 us-gaap Utilities Operating Expense
UtilitiesOperatingExpense
3756 usd
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
1382804 usd
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
1728996 usd
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
414 usd
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
16252 usd
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
434988 usd
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
379080 usd
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1264675 usd
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1011150 usd
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1165747 usd
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1193443 usd
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12237798 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11705613 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12300896 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11816585 shares
CY2020Q1 us-gaap Profit Loss
ProfitLoss
1331690 usd
CY2019Q1 us-gaap Profit Loss
ProfitLoss
1040414 usd
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
29582 usd
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5747 usd
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3192845 usd
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3222431 usd
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-235397 usd
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8764 usd
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
85116 usd
CY2019Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
92199 usd
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-29038 usd
CY2019Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
379080 usd
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1254996 usd
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1694187 usd
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-817633 usd
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2271836 usd
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
24750 usd
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10850 usd
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
846571 usd
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
599034 usd
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
101245 usd
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
108084 usd
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
464026 usd
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4470215 usd
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7672471 usd
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10166757 usd
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10164457 usd
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6161081 usd
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6178029 usd
CY2019Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
204102 usd
CY2020Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
186870 usd
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
157526 usd
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
144404 usd
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2389982 usd
CY2020Q1 us-gaap Payments For Proceeds From Deposit On Loan
PaymentsForProceedsFromDepositOnLoan
-201027 usd
CY2020Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3555832 usd
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
4380393 usd
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
4351743 usd
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
4179366 usd
CY2019 us-gaap Payments For Proceeds From Deposit On Loan
PaymentsForProceedsFromDepositOnLoan
-1071350 usd
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1566735 usd
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1046591 usd
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
148058 usd
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
148279 usd
CY2019Q1 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
996001 usd
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-125999 usd
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
FLEXIBLE SOLUTIONS INTERNATIONAL INC
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001069394
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
1.00 pure
CY2020Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
25000 shares
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
315888 shares
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y3M19D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
635000 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
660000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
600000 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
347000 shares
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1915585 usd
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
2799204 usd
CY2020Q1 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
743437 usd
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
96280 usd
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1275835 usd
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
16438 usd
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
13700 usd
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-994610 usd
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1093538 usd
CY2020Q1 FSI Shipping Cost
ShippingCost
4613 usd
CY2019Q1 FSI Shipping Cost
ShippingCost
4471 usd
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
199529 usd
CY2019Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
230652 usd
CY2020Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
2 segments
CY2019Q4 us-gaap Goodwill
Goodwill
2534275 usd
CY2020Q1 us-gaap Goodwill
Goodwill
2534275 usd
CY2019Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
500000 usd
CY2020Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
500000 usd
CY2019Q4 us-gaap Minority Interest
MinorityInterest
2550149 usd
CY2020Q1 us-gaap Minority Interest
MinorityInterest
2474162 usd
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2456148 usd
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3720823 usd
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32380417 usd
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34819594 usd
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1766678 usd
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1293495 usd
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
444898 usd
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
403062 usd
CY2020Q1 us-gaap Depreciation
Depreciation
99948 usd
CY2019Q1 us-gaap Depreciation
Depreciation
100169 usd
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2952000 usd
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2908000 usd
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
46576 usd
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
42466 usd
CY2019Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
200000 shares
CY2020Q1 us-gaap Proceeds From Loans
ProceedsFromLoans
usd
CY2019 us-gaap Proceeds From Loans
ProceedsFromLoans
1100000 usd
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
10000 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
56112 shares
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16437473 usd
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16491780 usd
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8429486 usd
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8471476 usd
CY2019Q4 us-gaap Noncurrent Assets
NoncurrentAssets
10327732 usd
CY2020Q1 us-gaap Noncurrent Assets
NoncurrentAssets
10176827 usd
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2560 usd
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
9276 usd
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1058641 usd
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1058641 usd
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.10
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.09
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
67015 usd
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
29264 usd
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
46576 usd
CY2020Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
42466 usd
CY2019Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
500000 usd
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20461376 usd
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
21605468 usd
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4110 usd
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4110 usd
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12240545 shares
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1000000 usd
CY2020Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
usd
CY2020Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P17Y
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
405670 usd
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
393959 usd
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
383535 usd
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
311699 usd
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
118468 usd
CY2019Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
114452 usd
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
usd
CY2019Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
590483 usd
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
789205 usd
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
705658 usd
CY2019Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.075
CY2019Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.075
CY2019Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.15
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1232762 usd
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1222707 usd
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-98928 usd
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
182293 usd
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
705658 usd
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3653 usd
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
204986 usd
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1222405 usd
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3162003 usd
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4634670 usd
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7857936 usd
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4695933 usd
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3412265 usd
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-98928 usd
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
182293 usd
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
24750 usd
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10850 usd
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29582 usd
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5747 usd
CY2020Q1 us-gaap Equity Method Investment Description Of Principal Activities
EquityMethodInvestmentDescriptionOfPrincipalActivities
Significant influence is generally deemed to exist if the Company's ownership interest in the voting stock of the investee ranges between 20% and 50%, although other factors, such as representation on the investee's board of directors, are considered in determining whether the equity method of accounting is appropriate.
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
usd
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
70925 usd
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
93155 usd
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
313496 usd
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
270652 usd
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
267362 usd
CY2019Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
4740867 usd
CY2020Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
7939833 usd
CY2019Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
4946960 usd
CY2020Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
3944746 usd
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
416950 usd
CY2020Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
297824 usd
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3818876 usd
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4660303 usd
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.31
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.35
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.36
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.99
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.85
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.41
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.99
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.15
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
67015 usd
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
29264 usd
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
181234 usd
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
388062 usd
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
636260 usd
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
965989 usd
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">(l) <i>Use of Estimates</i>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and would impact the results of operations and cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.45pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.45pt">Estimates and underlying assumptions are reviewed at each period end. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.45pt">Significant areas requiring the use of management estimates include assumptions and estimates relating to the valuation of goodwill and intangible assets, asset impairment analysis, share-based payments and warrants, valuation allowances for deferred income tax assets, determination of useful lives of property, equipment and leaseholds and intangible assets, and the valuation of inventory.</p>
CY2020Q1 FSI Distribution To Noncontrolling Interests
DistributionToNoncontrollingInterests
usd
CY2020Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">(q) <i>Risk Management.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s credit risk is primarily attributable to its accounts receivable. The amounts presented in the accompanying consolidated balance sheets are net of allowances for doubtful accounts, estimated by the Company&#8217;s management based on prior experience and the current economic environment. The Company is exposed to credit-related losses in the event of non-payment by customers. Credit exposure is minimized by dealing with only credit worthy counterparties. Accounts receivable for the Company&#8217;s three primary customers totaled $3,650,830 (48%) at March 31, 2020 (December 31, 2019 - $2,707,825 or 61%).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The credit risk on cash and cash equivalents is limited because the Company limits its exposure to credit loss by placing its cash and cash equivalents with major financial institutions. The Company maintains cash balances at financial institutions which at times exceed federally insured amounts. The Company has not experienced any material losses in such accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company is exposed to foreign exchange and interest rate risk to the extent that market value rate fluctuations materially differ from financial assets and liabilities, subject to fixed long-term rates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In order to manage its exposure to foreign exchange risks, the Company is closely monitoring the fluctuations in the foreign currency exchange rates and the impact on the value of cash and cash equivalents, accounts receivable, and accounts payable and accrued liabilities. The Company has not hedged its exposure to currency fluctuations.</p>
CY2020Q1 FSI Consulting Expenses
ConsultingExpenses
67311 usd
CY2019Q1 FSI Consulting Expenses
ConsultingExpenses
64779 usd
CY2020Q1 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
143002 usd
CY2020Q1 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
201027 usd
CY2019Q1 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
205262 usd
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
76509 usd
CY2020Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
usd
CY2019Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-125999 usd
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
113721 usd
CY2019Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
1000000 usd
CY2020Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
usd
CY2019Q1 FSI Cumulative Effect On Retained Earnings Net Of Tax
CumulativeEffectOnRetainedEarningsNetOfTax
-590483 usd
CY2020Q1 us-gaap Gain Loss On Sale Of Equity Investments
GainLossOnSaleOfEquityInvestments
140182 usd
CY2019Q1 us-gaap Gain Loss On Sale Of Equity Investments
GainLossOnSaleOfEquityInvestments
230652 usd
CY2020Q1 FSI Proceeds From Disposal Of Long Term Deposits
ProceedsFromDisposalOfLongTermDeposits
22084 usd
CY2019Q1 FSI Proceeds From Disposal Of Long Term Deposits
ProceedsFromDisposalOfLongTermDeposits
usd
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
304591 usd
CY2020Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1165850 usd
CY2019Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1383929 usd
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
16438 usd
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
337000 shares
CY2020Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
2.52
CY2019Q1 FSI Total Cash Cash Equivalents And Restricted Cash
TotalCashCashEquivalentsAndRestrictedCash
4695933 usd
CY2020Q1 FSI Total Cash Cash Equivalents And Restricted Cash
TotalCashCashEquivalentsAndRestrictedCash
3412265 usd
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M18D
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1600161 usd
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1545172 usd

Files In Submission

Name View Source Status
0001493152-20-008749-index-headers.html Edgar Link pending
0001493152-20-008749-index.html Edgar Link pending
0001493152-20-008749.txt Edgar Link pending
0001493152-20-008749-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
fsi-20200331.xsd Edgar Link pending
fsi-20200331_cal.xml Edgar Link unprocessable
fsi-20200331.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
fsi-20200331_lab.xml Edgar Link unprocessable
fsi-20200331_pre.xml Edgar Link unprocessable
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fsi-20200331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable